Clinigen (Portfolio of Established Medicines) Overview
- Status
-
Acquired/Merged
- Latest Deal Type
-
Buyout/LBO
- Financing Rounds
-
1
Clinigen (Portfolio of Established Medicines) General Information
Description
Manufacturer of pharmaceutical products and services intended to treat cancer patients. The business specializes in manufacturing car dioxane, savene, totect and ethyol medicines, thereby used to reduce the cumulative renal toxicity of cisplatin in patients with advanced ovarian cancer and for reduction of the toxic effects of radiation on normal oral tissues in patients with head and neck cancer.
Contact Information
Corporate Office
- Burton upon Trent
- England, United Kingdom
Corporate Office
- Burton upon Trent
- England, United Kingdom
Clinigen (Portfolio of Established Medicines) Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Clinigen (Portfolio of Established Medicines) Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Clinigen (Portfolio of Established Medicines) FAQs
-
Where is Clinigen (Portfolio of Established Medicines) headquartered?
Clinigen (Portfolio of Established Medicines) is headquartered in Burton upon Trent, United Kingdom.
-
What industry is Clinigen (Portfolio of Established Medicines) in?
Clinigen (Portfolio of Established Medicines)’s primary industry is Pharmaceuticals.
-
Is Clinigen (Portfolio of Established Medicines) a private or public company?
Clinigen (Portfolio of Established Medicines) is a Private company.
-
What is Clinigen (Portfolio of Established Medicines)’s current revenue?
The current revenue for Clinigen (Portfolio of Established Medicines) is .
-
Who are Clinigen (Portfolio of Established Medicines)’s investors?
Clinigen has invested in Clinigen (Portfolio of Established Medicines).
-
When was Clinigen (Portfolio of Established Medicines) acquired?
Clinigen (Portfolio of Established Medicines) was acquired on 09-Aug-2023.
-
Who acquired Clinigen (Portfolio of Established Medicines)?
Clinigen (Portfolio of Established Medicines) was acquired by CNX Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process